{"name": "Lycera",
 "permalink": "lycera",
 "crunchbase_url": "http://www.crunchbase.com/company/lycera",
 "homepage_url": "http://www.lycera.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "Pharm. for abnormal cell growth",
 "created_at": "Wed Jun 24 19:25:39 UTC 2009",
 "updated_at": "Fri Mar 04 04:13:57 UTC 2011",
 "overview": "\u003Cp\u003ELycera isa preclinical-stage biopharma company focused on small molecule immunomodulators for the treatment of rheumatoid arthritis, lupus erythematosis and inflammatory bowel disease\nLycera\u0026#8217;s first-in-class drugs are designed to treat immune disorders. Lycera\u00e2\u20ac\u2122s technology platforms include proprietary small molecules that modulate a target, which is central to cellular bioenergetics along with molecules that target the Th17 pathway.\u003C/p\u003E\n\n\u003Cp\u003EDrugs that emerge from the Lycera pipeline will represent first-in-class agents that have the potential for first-in-class oral efficacy without the adverse effects of current standard-of-care antiproliferative and immunosuppressive agents.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       71],
      "assets/images/resized/0005/0591/50591v1-max-150x150.png"],
     [[219,
       105],
      "assets/images/resized/0005/0591/50591v1-max-250x250.png"],
     [[219,
       105],
      "assets/images/resized/0005/0591/50591v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Tim",
      "last_name": "Mayleben",
      "permalink": "tim-mayleben",
      "image":
       {"available_sizes":
         [[[114,
            150],
           "assets/images/resized/0026/7086/267086v1-max-150x150.jpg"],
          [[190,
            250],
           "assets/images/resized/0026/7086/267086v1-max-250x250.jpg"],
          [[200,
            263],
           "assets/images/resized/0026/7086/267086v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$36M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://onbiovc.com/lycera-corp-series-a-36m/",
    "source_description": "Lycera Corp.: Series A $36M",
    "raised_amount": 36000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 5,
    "funded_day": 5,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "InterWest Partners",
         "permalink": "interwest-partners",
         "image":
          {"available_sizes":
            [[[117,
               56],
              "assets/images/resized/0002/9316/29316v1-max-150x150.png"],
             [[117,
               56],
              "assets/images/resized/0002/9316/29316v1-max-250x250.png"],
             [[117,
               56],
              "assets/images/resized/0002/9316/29316v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "ARCH Venture Partners",
         "permalink": "arch-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0003/6165/36165v2-max-150x150.png"],
             [[250,
               51],
              "assets/images/resized/0003/6165/36165v2-max-250x250.png"],
             [[300,
               62],
              "assets/images/resized/0003/6165/36165v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Clarus Ventures",
         "permalink": "clarus-ventures",
         "image":
          {"available_sizes":
            [[[150,
               82],
              "assets/images/resized/0005/0042/50042v2-max-150x150.png"],
             [[250,
               137],
              "assets/images/resized/0005/0042/50042v2-max-250x250.png"],
             [[308,
               169],
              "assets/images/resized/0005/0042/50042v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "EDF Ventures",
         "permalink": "edf-ventures",
         "image":
          {"available_sizes":
            [[[136,
               53],
              "assets/images/resized/0002/8458/28458v1-max-150x150.png"],
             [[136,
               53],
              "assets/images/resized/0002/8458/28458v1-max-250x250.png"],
             [[136,
               53],
              "assets/images/resized/0002/8458/28458v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Lycera",
    "address1": "",
    "address2": "",
    "zip_code": "",
    "city": "Ann Arbor",
    "state_code": "MI",
    "country_code": "USA",
    "latitude": 42.277416,
    "longitude": -83.733276}],
 "milestones":
  [{"description": "Lycera snags $307M anti-inflammatory discovery deal with Merck\r\n",
    "stoned_year": 2011,
    "stoned_month": 3,
    "stoned_day": 3,
    "source_url": "http://www.fiercebiotech.com/story/lycera-snags-307m-anti-inflammatory-discovery-deal-merck/2011-03-03?utm_medium=rss\u0026utm_source=rss",
    "source_text": "",
    "source_description": "Lycera snags $307M anti-inflammatory discovery deal with Merck",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Lycera",
      "permalink": "lycera"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        100],
       "assets/images/resized/0012/4928/124928v1-max-150x150.jpg"],
      [[250,
        167],
       "assets/images/resized/0012/4928/124928v1-max-250x250.jpg"],
      [[450,
        302],
       "assets/images/resized/0012/4928/124928v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}